≡

Multiplex Assay Kit for Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay)

GPIPLD; GPIPLDM; PIGPLD; PIGPLD1; Glycoprotein phospholipase D; Glycosyl-phosphatidylinositol-specific phospholipase D

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-89 85
EDTA plasma(n=5) 82-105 94
heparin plasma(n=5) 78-93 87

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 92-102% 99-105% 80-97% 82-95%
EDTA plasma(n=5) 80-91% 81-95% 96-105% 96-105%
heparin plasma(n=5) 85-98% 96-105% 78-103% 80-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:GPLD1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Clinical and Experimental Medicine Int J Clin Exp Med. 2012; 5(4): 306–309. Plasma glycosylphosphatidylinositol phospholipase D (GPI-PLD) and abdominal aortic aneurysm PubMed: PMC3443889
J Endocrinol Invest Serum glypican4 and glycosylphosphatidylinositol-specific phospholipase D levels are associated with adipose tissue insulin resistance in obese subjects with … Pubmed: 32816247
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPH975Hu01 Recombinant Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) Positive Control; Immunogen; SDS-PAGE; WB.
PAH975Hu01 Polyclonal Antibody to Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) WB; IHC; ICC; IP.
MAH975Hu21 Monoclonal Antibody to Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) WB; IHC; ICC; IP.
SEH975Hu ELISA Kit for Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMH975Hu Multiplex Assay Kit for Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.